|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.270 USD | -2.58% |
|
-4.43% | +25.83% |
| 14/05 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 23/07/2026 | 24/07/2026 | 27/07/2026 | 28/07/2026 | 30/07/2026 | |
|---|---|---|---|---|---|
| Last | USD 2.370 | USD 2.370 | USD 2.400 | USD 2.330 | USD 2.265 |
| Volume | 449,023 | 212,184 | 567,011 | 382,577 | 341,550 |
| Change | 0.00% | 0.00% | +1.27% | -2.92% | -2.58% |
| Opening | USD 2.340 | USD 2.350 | USD 2.390 | USD 2.420 | USD 2.310 |
| High | USD 2.385 | USD 2.390 | USD 2.460 | USD 2.420 | USD 2.360 |
| Low | USD 2.315 | USD 2.330 | USD 2.360 | USD 2.310 | USD 2.250 |
Performance
| 1 day | -2.58% | ||
| 1 week | -4.43% | ||
| Current month | -2.79% | ||
| 1 month | -3.62% | ||
| 3 months | +6.84% | ||
| 6 months | +9.42% | ||
| Current year | +25.83% | ||
| 1 year | +55.14% | ||
| 3 years | +41.56% | ||
| 5 years | +45.19% | ||
| 10 years | -64.94% |
Volumes
marketsDaily volume
341,550
Estimated daily volume
668,306
Avg. Volume 20 sessions
544,557
Daily volume ratio
1.23
Avg. Volume 20 sessions USD
1,236,144.39
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
187,731,925
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
180,452,064
Average Daily Capital Traded
0.66%
Indicators
Moving average 5 days
2.368
Moving average 20 days
2.358
Moving average 50 days
2.181
Moving average 100 days
2.229
Price spread / (MMA5)
+4.32%
Price spread / (MMA20)
+3.85%
Price spread / (MMA50)
-3.91%
Price spread / (MMA100)
-1.81%
STIM
RSI 9 days
61.16
RSI 14 days
60.42
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.58% | -4.43% | +55.14% | +41.56% | 188M | |
| -0.07% | +4.66% | +59.54% | +167.79% | 1,089B | |
| +0.19% | +4.65% | +59.13% | +59.68% | 643B | |
| +1.18% | +4.95% | +39.02% | +77.72% | 465B | |
| -1.69% | +8.81% | +39.38% | +33.67% | 359B | |
| -0.51% | +3.51% | +36.97% | +42.46% | 303B | |
| +1.50% | +3.40% | +17.71% | +17.41% | 267B | |
| +0.79% | +5.81% | -2.55% | -38.10% | 226B | |
| -0.91% | +6.45% | +28.36% | +66.41% | 212B | |
| -0.24% | +2.85% | +17.35% | +76.06% | 167B | |
| Average | -0.23% | +4.44% | +35.01% | +54.47% | 373.13B | |
| Weighted average by Cap. | +0.05% | +5.14% | +42.72% | +81.72% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
83e8293f34649dd1df24fcd46983a5f.nqxS3ucdXqlt2K0Rhr8G4GTwDpZ5iVnsK24jfWUrLHY.y9wV54pzMcFcq-lZ48pooRGlbMMX8BihGgIWEDBdfzX05Qi81FYWwCDoxg
| Date | Price | Volume | Total |
|---|---|---|---|
| 02:46:42 am | 2.265 | 100 | 315,567 |
| 02:46:37 am | 2.265 | 100 | 315,467 |
| 02:46:32 am | 2.265 | 100 | 315,367 |
| 02:46:27 am | 2.265 | 100 | 315,267 |
| 02:46:22 am | 2.265 | 100 | 315,167 |
| 02:46:22 am | 2.265 | 100 | 315,067 |
| 02:46:22 am | 2.260 | 3,370 | 314,967 |
| 02:46:22 am | 2.260 | 3,370 | 311,597 |
| 02:46:22 am | 2.265 | 100 | 308,227 |
| 02:46:22 am | 2.265 | 100 | 308,127 |
Course Extremes
| 1 week | 2.25 |  | 2.46 |
| 1 month | 2.25 | | 2.48 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.41 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +29.44% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
